Safety and Effectiveness of Balloons and Bands Discussed
WHO: Dr. Chand can discuss issues pertaining to clinically meaningful weight loss, measurement, length of patient follow-up and acceptable risk in relation to defined weight loss.
Dr. Chand is available for interviews at 2:30 p.m. today. Please call Stasia Thompson at (708) 417-5036.
WHAT: Dr. Chand can discuss:
- Today’s FDA advisory panel presentation on weight-loss device safety and efficacy
- New Arena obesity drug favored today by the FDA
- Trends in obesity and treatment
WHY: An estimated 42 percent of Americans may be obese by 2030, according to the Centers for Disease Control and Prevention. Health effects will cost government $550 billion. Currently more than a third of Americans are obese and that number is rising, especially in men and the elderly.
Dr. Chand is a recognized leader, innovator and expert in obesity and weight-loss surgery. Before joining Loyola in April, Dr. Chand headed endoscopic surgery at the Cleveland Clinic.
The Loyola Center for Metabolic Surgery and Bariatric Care at Melrose Park will open in July and will be headed by Dr. Chand.